In Vitro and In Vivo Activities of New Rifamycin Derivatives Against Mycobacterial Infections

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|26|3229-3238

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.26, 2004-10, pp. : 3229-3238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Vitro and In Vivo Activities of Acylated Derivatives of Isoniazid Against Mycobacterium Tuberculosis

By HEARN MICHAEL   CYNAMON MICHAEL  

Drug Design and Discovery, Vol. 18, Iss. 4, 2003-01 ,pp. : 103-108

Taylor & Francis Ltd

Access to resources Recommend Favorite

Fluoroquinolones as Chemotherapeutics Against Mycobacterial Infections

By  

Current Pharmaceutical Design, Vol. 10, Iss. 26, 2004-10 ,pp. : 3213-3220

Bentham Science Publishers

Access to resources Recommend Favorite

Liposome Technology for Drug Delivery Against Mycobacterial Infections

By  

Current Pharmaceutical Design, Vol. 10, Iss. 26, 2004-10 ,pp. : 3263-3274

Bentham Science Publishers

Access to resources Recommend Favorite

In-vivo and In-vitro Activities of Medicinal Plants on Ecto, Endo and Haemoparasitic Infections: A Review

By  

Current Clinical Pharmacology, Vol. 9, Iss. 3, 2014-08 ,pp. : 271-282

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro and In Vivo Activities of Ciprofloxacin and Levofloxacin against an SHV-5 Extended-Spectrum ß-Lactamase-Producing Klebsiella pneumoniae Strain

By  

Current Medicinal Chemistry, Vol. 9, Iss. 4, 2002-02 ,pp. : 437-442

Bentham Science Publishers

Access to resources Recommend Favorite